Accelerating global chemical product innovation and development

Scientific and regulatory support to market and sustain your products in any jurisdiction.

Competitive Advantage

Acta is a global scientific and regulatory consulting firm that assists companies that make and use chemicals with strategic commercialization planning and complex product registration and compliance matters.

We partner with our clients to help them get products quickly and efficiently to market — in any country or locale — and keep them there when challenged by a new regulatory regime, issue, or set of rules.

More About Us

Knowledge & Insights

  March 26, 2024
Memoranda
PFAS – What to Know Now, and What to Expect

Perfluoroalkyl and polyfluoroalkyl substances (PFAS) are attracting global legal, regulatory, commercial, and litigation attention as no other...

  July 16, 2024
Memoranda
EPA Grants TSCA Section 21 Petition Seeking Section 6 Rule Prohibiting Three PFAS Found in Fluorinated Plastic Containers

The U.S. Environmental Protection Agency (EPA) announced on July 11, 2024, that it granted a petition filed under Section 21 of the Toxic Substances...

  July 9, 2024
Memoranda
TSCA Reform — Eight Years Later: B&C, ELI, and GWU Conclude Best Available Conference

On June 26, 2024, Bergeson & Campbell, P.C. (B&C®), the Environmental Law Institute (ELI), and the George Washington University (GWU) Milken...

  July 5, 2024
Memoranda
Proposition 65: OEHHA Proposes Additional Changes to “Short-Form” Warning Option

On June 14, 2024, the California Office of Environmental Health Hazard Assessment (OEHHA) issued a notice proposing additional changes to its...

  June 21, 2024
Memoranda
EPA’s Proposed NMP Risk Management Rule Includes Requirements to Protect Workers and Consumers

On June 15, 2024, the U.S. Environmental Protection Agency (EPA) issued a proposed rule under Section 6(a) of the Toxic Substances Control Act (TSCA)...

  June 20, 2024
Memoranda
California Court Grants Injunction to Stop Prop 65 Warnings for Titanium Dioxide in Cosmetic and Personal Care Products

On June 12, 2024, the U.S. District Court for the Eastern District of California (District Court) issued an Order granting a preliminary injunction...

  May 30, 2024
Memoranda
OSHA HCS Amendments Primarily Align with GHS Rev 7

The U.S. Occupational Safety and Health Administration (OSHA) issued a final rule on May 20, 2024, that amends the Hazard Communication Standard (HCS)...

Seminars & Webinars

  December 18, 2023
Seminars & Webinars
PFAS — Determining PFAS Content in Your Suply Chain and Expanding Data Collection Practice, July 23, 2024, 11:00 a.m. – 12:00 p.m. (EDT), via webinar

Register now to join Bergeson & Campbell, P.C. (B&C®) for “Determining PFAS Content in Your Supply Chain and Expanding Data Collection...

  December 18, 2023
Seminars & Webinars
An Update on the EU Chemical Strategy for Sustainability, September 18, 2024, 11:00 a.m. – 12:00 p.m. (EDT), via webinar

Acta is pleased to present “An Update on the EU Chemical Strategy for Sustainability with EPPA.” More details will be posted closer to the...

  December 18, 2023
Seminars & Webinars
Consumer Labeling and the Status of GHS, November 12, 2024, 11:00 a.m. – 12:00 p.m. (EST), via webinar

B&C and Acta are pleased to present “Consumer Labeling and the Status of GHS.” More details will be posted closer to the webinar....

With offices in the U.S., UK, and Europe, and partners and agents in China, South Korea, Turkey, Mexico, and more, Acta offers expertise with regulatory programs and chemical product approvals in North America, Europe, South and Central America, and Asia.

Our Firms

our people

Experienced industry and agency scientists, including organic chemists, toxicologists, exposure experts, seven Ph.D.’s. Government affairs and regulatory specialists including nine high-level EPA alumni. Business strategists with decades of experience directing worldwide regulatory compliance.

Acta consultants manage products from concept to approval, delivering skills and experience with specific product areas in government and industry.

Our three affiliated firms -- B&C, Acta, and BCCM -- provide a full range of global support for the commercialization of chemicals, biocides, and products of industrial biotechnology, nanotechnology, and synthetic biology.